Remi Veneziano

George Mason University

$894,089

Attributed

$1,536,954

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $744.2K · FY2018–25

$1M$750K$500K$250K$0

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$1,536,954 · 3

By mechanism

R21$571,843 · 1

R01$535,416 · 1

R15$429,695 · 1

Top collaborators

Most similar at George Mason University

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “In Vivo”

Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
Lynn Briscoe · Leidos Biomedical Research, Inc.$94,216,744
Leonard Freedmand · Leidos Biomedical Research, Inc.$66,248,714
John Damon Chodera · Sloan-Kettering Inst Can Research$43,427,103
Tony Moody · Duke University$34,777,314
Alan D. Palkowitz · Indiana University Indianapolis$18,925,366

Research focus

In VivoInnovationNanoparticlePharmaceutical PreparationsAreaBiomaterial CompatibilityExtracellularLocationSkinResponseComplexClinical TrialsAntibiotic ResistanceCombinatorialAnti-Bacterial AgentsData SetDesignCeftazidimeBladderBurn InjuryAntigensBypassBiologicalCessation Of Life

Grant awards (5)

DNA-TEMPLATED NIR-II POTASSIUM REPORTERS FOR NONINVASIVE IMAGING OF IONIC ACTIVITY IN DEEP TISSUE$535,416

R01 · FY2025 · EB

Enzyme-Powered Self-Propelled DNA Nanoparticles for Disruption and Antibiotic Delivery in Topical Biofilms$208,794

R21 · FY2025 · EB

Enzyme-Powered Self-Propelled DNA Nanoparticles for Disruption and Antibiotic Delivery in Topical Biofilms$182,802

R21 · FY2024 · EB

Enzyme-Powered Self-Propelled DNA Nanoparticles for Disruption and Antibiotic Delivery in Topical Biofilms$180,247

R21 · FY2022 · EB

Exosomes on a Chip: Real-time monitoring of intercellular communication and immune responses during infection$429,695

R15 · FY2018 · AI · contact PI